ZB
CMD

Zions Bancorporation’s Cantel Medical Corporation CMD Stock Holding History

Zions Bancorporation’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,871
Closed -$469K – 1024
2021
Q1 		$469K Sell
5,871
-31
-0.5% -$2.42K 0.05% 156
2020
Q4 		$465K Buy
5,902
+266
+5% +$15.6K 0.06% 135
2020
Q3 		$248K Sell
5,636
-2
-0% -$99 0.04% 192
2020
Q2 		$249K Buy
5,638
+2,676
+90% +$99.8K 0.04% 178
2020
Q1 		$106K Buy
2,962
+341
+13% +$19.4K 0.02% 259
2019
Q4 		$186K Sell
2,621
-614
-19% -$44.5K 0.03% 235
2019
Q3 		$242K Buy
3,235
+20
+0.6% +$1.7K 0.03% 202
2019
Q2 		$259K Buy
3,215
+187
+6% +$13.1K 0.04% 176
2019
Q1 		$203K Buy
+3,028
New +$229K 0.03% 210
2018
Q2 		– Sell
-3,094
Closed -$345K – 740
2018
Q1 		$345K Buy
+3,094
New +$347K 0.08% 91
2017
Q4 		– Sell
-2,998
Closed -$282K – 1033
2017
Q3 		$282K Buy
+2,998
New +$237K 0.04% 213

Zions Bancorporation's CMD Position: Q2 2021 in Review

Zions Bancorporation sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 5,871 shares — an estimated $469K sold.

Zions Bancorporation first reported a position in CMD in Q3 2017 and held it in 11 quarters. The position peaked at $469K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Zions Bancorporation reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Zions Bancorporation sold 5,871 Cantel Medical Corporation shares in Q2 2021, an estimated $469K.
  • Zions Bancorporation first reported a position in Cantel Medical Corporation in Q3 2017 and held it in 11 quarters.
  • Zions Bancorporation's Cantel Medical Corporation position peaked at $469K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Zions Bancorporation's 13F filing for Q2 2021, filed 11 Aug 2021.